The future of chemical probes is diversity
Abstract
A graphical abstract is available for this content
- This article is part of the themed collection: Chemical Probes
a
Institute of Pharmaceutical Chemistry and Structural Genomics Consortium, Goethe-University Frankfurt, Buchmann Institute for Life Sciences, Max-von-Laue-Str. 15, 60438 Frankfurt am Main, Germany
E-mail:
Susanne.mueller-knapp@bmls.de
b The Chemical Probes Portal, The Institute of Cancer Research, London, UK
c
Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, 3206 Marsico Hall, 125 Mason Farm Road, Chapel Hill, NC 27599-7363, USA
E-mail:
@email.unc.edu
d School of Pharmaceutical Sciences, Nanjing Tech University, No. 30 South Puzhu Road, Nanjing 211816, People's Republic of China
e
Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia
E-mail:
Jonathan.Baell@monash.edu
f Australian Translational Medicinal Chemistry Facility (ATMCF), Monash University, Parkville, Victoria 3052, Australia
A graphical abstract is available for this content
S. Müller, S. Frye and J. Baell, RSC Med. Chem., 2022, 13, 1438 DOI: 10.1039/D2MD90036J
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content